UBS Group
TNDM icon

UBS Group’s Tandem Diabetes Care TNDM Stock Holding History

UBS Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.1M Hold
5,178,570
– – 0.01% 1314
2026
Q1 		$99.3M Buy
5,178,570
+2,433,258
+89% +$52.9M 0.01% 1056
2025
Q4 		$60.3M Hold
2,745,312
– – 0.01% 1431
2025
Q3 		$33.3M Hold
2,745,312
– – 0.01% 2031
2025
Q2 		$51.2M Hold
2,745,312
– – 0.01% 1504
2025
Q1 		$52.6M Hold
2,745,312
– – 0.01% 1435
2024
Q4 		$98.9M Hold
2,745,312
– – 0.02% 938
2024
Q3 		$116M Hold
2,745,312
– – 0.03% 653
2024
Q2 		$111M Hold
2,745,312
– – 0.03% 599
2024
Q1 		$97.2M Buy
+2,745,312
New +$73.6M 0.02% 660

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

UBS Group's TNDM Position: Q2 2026 in Review

UBS Group reduced its Tandem Diabetes Care (TNDM) stake by 44% in Q2 2026, selling an estimated $15.7M and leaving 1,146,580 shares worth $17.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2846.

UBS Group first reported a position in TNDM in Q4 2014 and has held it in 47 quarters since. The position peaked at $60.9M in Q4 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • UBS Group held 1,146,580 shares of Tandem Diabetes Care worth $17.3M as of Q2 2026.
  • UBS Group sold 901,221 Tandem Diabetes Care shares in Q2 2026, an estimated $15.7M.
  • Tandem Diabetes Care made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2846 holding.
  • UBS Group first reported a position in Tandem Diabetes Care in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Tandem Diabetes Care position peaked at $60.9M in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.